Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The US Food and Drug Administration (FDA) has approved AstraZeneca's Iressa (gefitinib) tablets, 250mg once daily, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations, as detected by an FDA-approved test.

  • A new affordable, non-invasive test that detects electrical activity in the brain may predict the risk of Alzheimer's disease, scientists say. The research was published in the Journal of Alzheimer's Disease.

    [adsense:336x280:8701650588]

  • Bureau of Pharma PSUs of India (BPPI) is to provide Rs. 2.5 lakhs help for seeting up your Jan Aushadhi Stores (JAS). Any NGO/Charitable Society/Institution/Self Help Group can also open the Jan Aushadhi store outside the hospital premises.

  • Scientists have for the first time explained the mechanisms that the dengue virus has developed to optimise its ability to cause outbreaks as it travels across the globe to new places and revisits old ones. Dengue virus has been spreading throughout warm regions of the world, prompting the virus to adapt to new environments.

Subscribe to Pharma News